Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia
Clinical trial NCT04172844 · TERMINATED
Trial details
- NCT number
- NCT04172844
- Sponsor
- Medical College of Wisconsin
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2021-12-12
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.